Corrigendum to "Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-κB signaling" [BIOCHEM BIOPH RES CO volume 509 (issue 1) (29 January 2019) pages 16-23]
- PMID: 31703839
- DOI: 10.1016/j.bbrc.2019.10.002
Corrigendum to "Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-κB signaling" [BIOCHEM BIOPH RES CO volume 509 (issue 1) (29 January 2019) pages 16-23]
Erratum for
-
Leukocyte immunoglobulin-like receptor B4 (LILRB4) negatively mediates the pathological cardiac hypertrophy by suppressing fibrosis, inflammation and apoptosis via the activation of NF-κB signaling.Biochem Biophys Res Commun. 2019 Jan 29;509(1):16-23. doi: 10.1016/j.bbrc.2018.11.137. Epub 2018 Dec 20. Biochem Biophys Res Commun. 2019. PMID: 30581005
Publication types
LinkOut - more resources
Full Text Sources
